Chinese researchers achieved historic milestones by successfully utilizing stem-cell-derived islet cell transplants to restore natural insulin production in patients with type 1 diabetes, allowing them to remain completely insulin-free for extended periods. While these published clinical cases represent monumental scientific breakthroughs in regenerative medicine and cell therapy, medical experts emphasize that these treatments are still experimental therapies requiring broader, long-term multi-patient validation before being declared a universal public cure.